Learning Objectives:
- Comprehensive Understanding of Stroke Prevention in Atrial Fibrillation
- Navigating Antithrombotic Therapies for Stroke Prevention
- Translating Research into Practice for Enhanced Stroke Care
Scientific Program:
– Chair Introductions: Valeria Caso, Italy
– Burden of atrial fibrillation (AF) in stroke care: Cecilia Bahit, Argentina
– Antithrombotic Guidelines and unmet needs: Jan Scheitz, Germany
– Completed Phase II, and ongoing Phase III, Factor XI(a) inhibitor trials in AF or non-cardioembolic ischemic stroke: Ashkan Shoamanesh, Canada
– Q&A Discussion
Date & Time: September 19th, 3pm (CEST)
This webinar is supported by an unrestricted educational grant by Bayer AG.